Loading…
β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals
β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA...
Saved in:
Published in: | Microbiology and immunology 2021-09, Vol.65 (9), p.343-351 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413 |
---|---|
cites | cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413 |
container_end_page | 351 |
container_issue | 9 |
container_start_page | 343 |
container_title | Microbiology and immunology |
container_volume | 65 |
creator | Dewake, Nanae Ma, Xiangtao Sato, Kayo Nakatsu, Susumu Yoshimura, Kenji Eshita, Yoshiyuki Fujinaka, Hidetake Yano, Yoshitaka Yoshinari, Nobuo Yoshida, Akihiro |
description | β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria. |
doi_str_mv | 10.1111/1348-0421.12884 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2514603588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2570164057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</originalsourceid><addsrcrecordid>eNqFkbFu2zAURYmiQeOknbMFBLJ0kUOKpESPgdE6BmxkaWfikaJsBpLokFIMbf2Efks_pB_RLwkdJxmy9C0XeDjv4uFehC4omdI015RxmRGe0ynNpeQf0ORt8xFNCJMiEwUhp-gsxntC8jKX_BM6ZUwWRBRsgvzfP_9-_V40oxlD2Nredc5gMK7Crts67fqI-63FGkxvg4MGb4Lf91sMXYW187VrWlz70ELvfIf1iOOwC7Bx3cY9JnrXwMNgsfFta7sITfyMTuok9suLnqOf37_9mN9mq7vFcn6zygxnBc9yKg0BgBljdSUYNTNelTOQVIMlUBpZM11JYXUxY0ZWXLOalILQ2lDQhlN2jr4efXfBpw9ir1oXjW0a6KwfosoF5QVhQsqEXr1D7_0QuvRdokpCC05EmajrI2WCjzHYWu2CayGMihJ16EIdkleH5NVzF-ni8sV30K2t3vjX8BMgjsDeNXb8n59aL9dH4yfyW5aR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570164057</pqid></control><display><type>article</type><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><source>Wiley</source><source>Alma/SFX Local Collection</source><creator>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</creator><creatorcontrib>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</creatorcontrib><description>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</description><identifier>ISSN: 0385-5600</identifier><identifier>EISSN: 1348-0421</identifier><identifier>DOI: 10.1111/1348-0421.12884</identifier><identifier>PMID: 33860563</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Antibacterial activity ; Antibacterial agents ; Bacteria ; biofilm ; Biofilms ; coaggregation ; Commensals ; gingivitis ; Minimum inhibitory concentration ; Periodontal diseases ; supragingival plaque ; β‐glycyrrhetinic acid (BGA)</subject><ispartof>Microbiology and immunology, 2021-09, Vol.65 (9), p.343-351</ispartof><rights>2021 The Societies and John Wiley & Sons Australia, Ltd.</rights><rights>This article is protected by copyright. All rights reserved.</rights><rights>2021 The Societies and John Wiley & Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</citedby><cites>FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</cites><orcidid>0000-0003-1296-9022</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33860563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dewake, Nanae</creatorcontrib><creatorcontrib>Ma, Xiangtao</creatorcontrib><creatorcontrib>Sato, Kayo</creatorcontrib><creatorcontrib>Nakatsu, Susumu</creatorcontrib><creatorcontrib>Yoshimura, Kenji</creatorcontrib><creatorcontrib>Eshita, Yoshiyuki</creatorcontrib><creatorcontrib>Fujinaka, Hidetake</creatorcontrib><creatorcontrib>Yano, Yoshitaka</creatorcontrib><creatorcontrib>Yoshinari, Nobuo</creatorcontrib><creatorcontrib>Yoshida, Akihiro</creatorcontrib><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><title>Microbiology and immunology</title><addtitle>Microbiol Immunol</addtitle><description>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</description><subject>Antibacterial activity</subject><subject>Antibacterial agents</subject><subject>Bacteria</subject><subject>biofilm</subject><subject>Biofilms</subject><subject>coaggregation</subject><subject>Commensals</subject><subject>gingivitis</subject><subject>Minimum inhibitory concentration</subject><subject>Periodontal diseases</subject><subject>supragingival plaque</subject><subject>β‐glycyrrhetinic acid (BGA)</subject><issn>0385-5600</issn><issn>1348-0421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkbFu2zAURYmiQeOknbMFBLJ0kUOKpESPgdE6BmxkaWfikaJsBpLokFIMbf2Efks_pB_RLwkdJxmy9C0XeDjv4uFehC4omdI015RxmRGe0ynNpeQf0ORt8xFNCJMiEwUhp-gsxntC8jKX_BM6ZUwWRBRsgvzfP_9-_V40oxlD2Nredc5gMK7Crts67fqI-63FGkxvg4MGb4Lf91sMXYW187VrWlz70ELvfIf1iOOwC7Bx3cY9JnrXwMNgsfFta7sITfyMTuok9suLnqOf37_9mN9mq7vFcn6zygxnBc9yKg0BgBljdSUYNTNelTOQVIMlUBpZM11JYXUxY0ZWXLOalILQ2lDQhlN2jr4efXfBpw9ir1oXjW0a6KwfosoF5QVhQsqEXr1D7_0QuvRdokpCC05EmajrI2WCjzHYWu2CayGMihJ16EIdkleH5NVzF-ni8sV30K2t3vjX8BMgjsDeNXb8n59aL9dH4yfyW5aR</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Dewake, Nanae</creator><creator>Ma, Xiangtao</creator><creator>Sato, Kayo</creator><creator>Nakatsu, Susumu</creator><creator>Yoshimura, Kenji</creator><creator>Eshita, Yoshiyuki</creator><creator>Fujinaka, Hidetake</creator><creator>Yano, Yoshitaka</creator><creator>Yoshinari, Nobuo</creator><creator>Yoshida, Akihiro</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1296-9022</orcidid></search><sort><creationdate>202109</creationdate><title>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</title><author>Dewake, Nanae ; Ma, Xiangtao ; Sato, Kayo ; Nakatsu, Susumu ; Yoshimura, Kenji ; Eshita, Yoshiyuki ; Fujinaka, Hidetake ; Yano, Yoshitaka ; Yoshinari, Nobuo ; Yoshida, Akihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibacterial activity</topic><topic>Antibacterial agents</topic><topic>Bacteria</topic><topic>biofilm</topic><topic>Biofilms</topic><topic>coaggregation</topic><topic>Commensals</topic><topic>gingivitis</topic><topic>Minimum inhibitory concentration</topic><topic>Periodontal diseases</topic><topic>supragingival plaque</topic><topic>β‐glycyrrhetinic acid (BGA)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dewake, Nanae</creatorcontrib><creatorcontrib>Ma, Xiangtao</creatorcontrib><creatorcontrib>Sato, Kayo</creatorcontrib><creatorcontrib>Nakatsu, Susumu</creatorcontrib><creatorcontrib>Yoshimura, Kenji</creatorcontrib><creatorcontrib>Eshita, Yoshiyuki</creatorcontrib><creatorcontrib>Fujinaka, Hidetake</creatorcontrib><creatorcontrib>Yano, Yoshitaka</creatorcontrib><creatorcontrib>Yoshinari, Nobuo</creatorcontrib><creatorcontrib>Yoshida, Akihiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Microbiology and immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dewake, Nanae</au><au>Ma, Xiangtao</au><au>Sato, Kayo</au><au>Nakatsu, Susumu</au><au>Yoshimura, Kenji</au><au>Eshita, Yoshiyuki</au><au>Fujinaka, Hidetake</au><au>Yano, Yoshitaka</au><au>Yoshinari, Nobuo</au><au>Yoshida, Akihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals</atitle><jtitle>Microbiology and immunology</jtitle><addtitle>Microbiol Immunol</addtitle><date>2021-09</date><risdate>2021</risdate><volume>65</volume><issue>9</issue><spage>343</spage><epage>351</epage><pages>343-351</pages><issn>0385-5600</issn><eissn>1348-0421</eissn><abstract>β‐Glycyrrhetinic acid (BGA) is a natural antibacterial agent. Previous studies reported that BGA has antibacterial effects against several bacteria. This study evaluated the effects of BGA on the regulation of supragingival plaque bacteria. First, the minimum inhibitory concentrations (MICs) of BGA against oral bacteria were measured. Next, the minimum concentrations for inhibition of biofilm formation were evaluated against Streptococcus mutans and Streptococcus sobrinus, possessing insoluble glucan synthesis abilities. The MICs of biofilm formation by these bacteria ranged from 1/8 to 2× MIC. Furthermore, the inhibition effects of BGA against the coaggregation of Porphyromonas gingivalis and Streptococcus gordonii were evaluated. BGA at 32 or 64 μg/mL inhibited the coaggregation of these bacteria after a 30 min incubation. Lastly, the inhibition effects of BGA against human supragingival plaque bacteria were evaluated. Human supragingival plaque samples were obtained from 12 healthy donors. The inhibition effects of BGA against biofilm formation by these plaque bacteria were evaluated. Of 12 samples, the biofilm formation by 11 was significantly attenuated by 128–256 μg/mL of BGA. The number of colony forming units in these biofilms was also significantly attenuated. In conclusion, it was revealed that BGA inhibits the growth and biofilm formation of bacteria, furthermore, the same effect was confirmed with supragingival plaque bacteria. BGA is a good candidate for a natural agent that prevents the outbreak and progression of periodontal disease because it suppresses not only the growth and biofilm formation of bacteria, but also the coaggregation of P. gingivalis with plaque bacteria.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33860563</pmid><doi>10.1111/1348-0421.12884</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-1296-9022</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0385-5600 |
ispartof | Microbiology and immunology, 2021-09, Vol.65 (9), p.343-351 |
issn | 0385-5600 1348-0421 |
language | eng |
recordid | cdi_proquest_miscellaneous_2514603588 |
source | Wiley; Alma/SFX Local Collection |
subjects | Antibacterial activity Antibacterial agents Bacteria biofilm Biofilms coaggregation Commensals gingivitis Minimum inhibitory concentration Periodontal diseases supragingival plaque β‐glycyrrhetinic acid (BGA) |
title | β‐Glycyrrhetinic acid inhibits the bacterial growth and biofilm formation by supragingival plaque commensals |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A44%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2%E2%80%90Glycyrrhetinic%20acid%20inhibits%20the%20bacterial%20growth%20and%20biofilm%20formation%20by%20supragingival%20plaque%20commensals&rft.jtitle=Microbiology%20and%20immunology&rft.au=Dewake,%20Nanae&rft.date=2021-09&rft.volume=65&rft.issue=9&rft.spage=343&rft.epage=351&rft.pages=343-351&rft.issn=0385-5600&rft.eissn=1348-0421&rft_id=info:doi/10.1111/1348-0421.12884&rft_dat=%3Cproquest_cross%3E2570164057%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4364-218c0aaa933fd531c94d79a81bae0a7c8f3bd85eb693c8d4b3f07501fc1abc413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2570164057&rft_id=info:pmid/33860563&rfr_iscdi=true |